02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 11.63
−1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 14.47x
- P/E 2027E
- 11.89x
- P/E 2028E
- 10.45x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 10.35x
- PEG TTM
- 0.66x
- Price / book
- 2.66x
- Price / sales
- 1.59x
- Price / cash flow
- 12.44x
Enterprise value
- Enterprise value
- HKD 26.0B
- EV / sales
- 1.41x
- EV / EBITDA
- 6.30x
- EV / EBIT
- 7.80x
- Market cap
- HKD 29.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026